Information Library
Phase IIIb/IV
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by:
- Most Recent
- Title
-
The New Health Clinical Brochure
August 31, 2010
Japanese version available for download. -
ISPOR 13th Annual European Congress
November 6 - November 9, 2010
Quintiles will be exhbiting, sponsoring and presenting at ISPOR's 13th Annual European Congress, November 6-9, 2010 in Prague. -
A Focus on CNS
July 28, 2010
Quintiles is your ally for broad and deep CNS expertise in every aspect of the drug development process. -
Precision Planning
June 24, 2010
For a Global trial, our customer worked with multiple players, including affiliates and an external CRO. With data coming from isolated teams across numerous language -
Post-Market Advantage
June 18, 2010
Get 360-degree insight with an ally who knows you. -
Targeting Oncology
June 2, 2010
Learn more about Quintiles leadership in oncology product development and commercialization. -
Data-Driven Market Success
May 14, 2010
Steering the largest post-marketing diabetes study ever conducted, Quintiles was able to stay flexible and successfully scale up to an eight-country study with more than 55,000 patients, even with the operational challenges of multiple affiliates and staggered database locks. -
Clinical – smarter trials, accelerated outcomes
April 2, 2010
Quintiles will work with you to plan and execute the smartest clinical trials and post-marketing studies, informed by a holistic view of strategic, operational, regulatory and marketplace issues. -
The Right Balance
March 31, 2010
Through creative strategies and proactive measures, learn how Quintiles achieved both the recruitment targets and database lock eight months early. -
PharmAsia News Article Reprint
March 1, 2010
Quintiles Asia Executives Say CROs Must Evaluate, Adjust To New Health Landscape: An Interview With PharmAsia News.